Nivagen Pharmaceuticals
nivagen.com
Actively hiring
Biotechnology
Consumer Goods
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Telegraph Hill Partners
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Telegraph Hill Partners Similar startupsby what they do, their industry and backers
WELCOME TO THE NEW HOME FOR MINISIS A very warm welcome to the new home for MINISIS products and solutions here at Soutron Global.
Buy your next home. The Trade Up Program helps clients buy a New Home first, move once, and sell their Old Home later.
Expert home telepsychiatry services with licensed providers in Montana, Idaho, & Alaska. Most insurance accepted, no referral needed…
Rebolt replaces 10 tools with one AI-powered platform for home service pros.
Alaro builds home intelligence products for Indian families. Our AI-powered cameras understand your home rather than just recording it.
McIntosh handcrafts legendary home audio products for home stereo and home theater systems. Our audio products have been made in the USA…
News
Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals
Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines.
Read more
Report
PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market
PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid medicines, today announced the acquisition of Nivagen Pharmaceuticals, Inc. ("Nivagen"), a California-based pharmaceutical c
Read more
Report
PAI Pharma Acquires Nivagen Pharmaceuticals to Expand Sterile Injectable and RTU Hospital Offerings
Proud to share this exciting milestone as Nivagen Pharmaceuticals joins forces with PAI Pharma - strengthening domestic sterile injectable manufacturing and expanding our ready-to-use product offerings to better serve hospitals and healthcare systems. Gra
Read more
Report
Nivagen Pharmaceuticals, Inc. (CA)successfully completed the United States Food and Drug Administration (USFDA) Post-marketing Adverse Drug Experience (PADE) Inspection.
Nivagen Pharmaceuticals Inc. (Nivagen), located in Sacramento, California, USA has successfully completed the United States Food and Drug Administration (USFDA) Post-marketing Adverse Drug Experience (PADE) Inspection. The inspection was closed with zero
Read more
Report
Nivagen Pharmaceuticals, Inc. (CA) has received ANDA approval for Sodium Bicarbonate Injection USP, 8.4%.from U.S. FDA
Nivagen announced today that it has received FDA approval for its Sodium Bicarbonate products. Sodium Bicarbonate is the newest addition to Nivagen's portfolio of generics and 505 B2 drugs. Nivagen's approval will immediately help to address the current s
Read more
Report